NeuroOne Medical Technologies Corporation Selling, General and Administrative Expense
NeuroOne Medical Technologies Corporation (NMTC) reported Selling, General and Administrative Expense of $2.18 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-13
- NeuroOne Medical Technologies Corporation selling, general and administrative expense for the quarter ending 2026-06-30 was $2.18M, a 34.76% increase year-over-year.
- NeuroOne Medical Technologies Corporation selling, general and administrative expense for the quarter ending 2026-03-31 was $1.92M, a 1.08% decline year-over-year.
- NeuroOne Medical Technologies Corporation selling, general and administrative expense for the quarter ending 2025-12-31 was $1.89M, a 7.73% decline year-over-year.
- NeuroOne Medical Technologies Corporation selling, general and administrative expense for the quarter ending 2025-09-30 was $1.78M, a 3.39% decline year-over-year.
- NeuroOne Medical Technologies Corporation selling, general and administrative expense for fiscal 2025 was $7.38M, a 6.55% decline from fiscal 2024.
- NeuroOne Medical Technologies Corporation selling, general and administrative expense for fiscal 2024 was $7.90M, a 14.08% increase from fiscal 2023.
- NeuroOne Medical Technologies Corporation selling, general and administrative expense for fiscal 2023 was $6.93M, a 0.76% decline from fiscal 2022.
- NeuroOne Medical Technologies Corporation selling, general and administrative expense for fiscal 2022 was $6.98M, a 11.49% increase from fiscal 2021.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.18M 10-Q · filed 2026-08-13 | $4.10M derived: sum of 2 quarters · filed 2026-08-13 | $5.99M 10-Q · filed 2026-08-13 | $7.77M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $1.92M 10-Q/A · filed 2026-06-12 | $3.80M 10-Q/A · filed 2026-06-12 | $5.59M derived: sum of 3 quarters · filed 2026-06-12 | $7.21M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $1.89M 10-Q · filed 2026-02-17 | $3.67M derived: sum of 2 quarters · filed 2026-02-17 | $5.29M derived: sum of 3 quarters · filed 2026-08-13 | $7.23M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-09-30 | $1.78M derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-17 | $3.40M derived: sum of 2 quarters · filed 2026-08-13 | $5.34M derived: sum of 3 quarters · filed 2026-08-13 | $7.38M 10-K · filed 2025-12-17 |
| 2025-06-30 | $1.62M 10-Q · filed 2026-08-13 | $3.56M derived: sum of 2 quarters · filed 2026-08-13 | $5.60M 10-Q · filed 2026-08-13 | $7.45M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $1.94M 10-Q/A · filed 2026-06-12 | $3.98M 10-Q/A · filed 2026-06-12 | $5.83M derived: sum of 3 quarters · filed 2026-06-12 | $7.71M derived: sum of 4 quarters · filed 2026-06-12 |
| 2024-12-31 | $2.04M 10-Q · filed 2026-02-17 | $3.89M derived: sum of 2 quarters · filed 2026-02-17 | $5.77M derived: sum of 3 quarters · filed 2026-02-17 | $7.77M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-09-30 | $1.84M derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-17 | $3.73M derived: sum of 2 quarters · filed 2025-12-17 | $5.73M derived: sum of 3 quarters · filed 2025-12-17 | $7.90M 10-K · filed 2025-12-17 |
| 2024-06-30 | $1.88M 10-Q · filed 2025-08-14 | $3.88M derived: sum of 2 quarters · filed 2025-08-14 | $6.06M 10-Q · filed 2025-08-14 | $7.64M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $2.00M 10-Q · filed 2025-05-13 | $4.18M 10-Q · filed 2025-05-13 | $5.76M derived: sum of 3 quarters · filed 2025-05-13 | $7.62M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $2.17M 10-Q · filed 2025-02-12 | $3.75M derived: sum of 2 quarters · filed 2025-02-12 | $5.61M derived: sum of 3 quarters · filed 2025-02-12 | $7.44M derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-09-30 | $1.58M derived: 10-K 12 month − 10-Q 9 month · filed 2024-12-17 | $3.44M derived: sum of 2 quarters · filed 2024-12-17 | $5.26M derived: sum of 3 quarters · filed 2024-12-17 | $6.93M 10-K · filed 2024-12-17 |
| 2023-06-30 | $1.86M 10-Q · filed 2024-08-14 | $3.68M derived: sum of 2 quarters · filed 2024-08-14 | $5.35M 10-Q · filed 2024-08-14 | $7.24M derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $1.82M 10-Q · filed 2024-05-14 | $3.48M 10-Q · filed 2024-05-14 | $5.37M derived: sum of 3 quarters · filed 2024-05-14 | $6.90M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $1.66M 10-Q · filed 2024-02-13 | $3.55M derived: sum of 2 quarters · filed 2024-02-13 | $5.08M derived: sum of 3 quarters · filed 2024-02-13 | $6.90M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-09-30 | $1.89M derived: 10-K 12 month − 10-Q 9 month · filed 2023-12-15 | $3.42M derived: sum of 2 quarters · filed 2023-12-15 | $5.24M derived: sum of 3 quarters · filed 2023-12-15 | $6.98M 10-K · filed 2023-12-15 |
| 2022-06-30 | $1.53M 10-Q · filed 2023-08-14 | $3.35M derived: sum of 2 quarters · filed 2023-08-14 | $5.09M 10-Q · filed 2023-08-14 | $6.71M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $1.82M 10-Q · filed 2023-05-12 | $3.56M 10-Q · filed 2023-05-12 | $5.18M derived: sum of 3 quarters · filed 2023-05-12 | $7.31M derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | $1.74M 10-Q · filed 2023-02-13 | $3.37M derived: sum of 2 quarters · filed 2023-02-13 | $5.50M derived: sum of 3 quarters · filed 2023-02-13 | |
| 2021-09-30 | $1.62M derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-22 | $3.75M derived: sum of 2 quarters · filed 2022-12-22 | $6.26M 10-K · filed 2022-12-22 | |
| 2021-06-30 | $2.13M 10-Q · filed 2022-08-11 | $4.64M 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B |